Study of Patients With Metastatic Renal Cell Carcinoma and Sarcopenia Finds Reduced Survival Following Cytoreductive Nephrectomy
source: pixabay.com

Study of Patients With Metastatic Renal Cell Carcinoma and Sarcopenia Finds Reduced Survival Following Cytoreductive Nephrectomy

As featured recently in the Cancer Therapy Advisor, a study has been conducted on patients diagnosed with metastatic renal cell carcinoma (mRCC), who also have elevated inflammation, and sarcopenia. The…

Continue Reading Study of Patients With Metastatic Renal Cell Carcinoma and Sarcopenia Finds Reduced Survival Following Cytoreductive Nephrectomy
Study of the Week: Method for Predicting Severe Cardiac Events Following Renal Cell Carcinoma Treatment
source: pixabay.com

Study of the Week: Method for Predicting Severe Cardiac Events Following Renal Cell Carcinoma Treatment

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Method for Predicting Severe Cardiac Events Following Renal Cell Carcinoma Treatment

Doctors Receive Nobel Prize for Development in Renal Cell Carcinoma Treatment

Research by three doctors provided a basis for tyrosine kinase inhibitors (TKI) and offered advancements in treatment for renal cell carcinoma (RCC) patients. Two such TKIs, sunitinib and sorafenib, remain…

Continue Reading Doctors Receive Nobel Prize for Development in Renal Cell Carcinoma Treatment

Study Shows Promising Results for Radiotherapy to Treat Oligometastatic Renal Cell Carcinoma

According to a recent article from MedPage Today, the results from a small prospective study show that sequential radiotherapy (RT) is successful in delaying systemic therapy for oligometastatic renal cell…

Continue Reading Study Shows Promising Results for Radiotherapy to Treat Oligometastatic Renal Cell Carcinoma
Study of Non-Clear Cell Renal Cell Carcinoma Finds Strong Link to Proliferative Disease
source: pixabay.com

Study of Non-Clear Cell Renal Cell Carcinoma Finds Strong Link to Proliferative Disease

Non-clear cell renal cell carcinoma (nccRCC) has recently been found to have a very strong connection with various subtypes of proliferative disease. Further, this condition was found to have a…

Continue Reading Study of Non-Clear Cell Renal Cell Carcinoma Finds Strong Link to Proliferative Disease
ICYMI: Trial Begins to Evaluate Savolitinib and IMFINZI for Renal Cell Carcinoma
Photo by Robina Weermeijer on Unsplash

ICYMI: Trial Begins to Evaluate Savolitinib and IMFINZI for Renal Cell Carcinoma

According to a news release, researchers from biopharmaceutical company HUTCHMED and pharmaceutical company AstraZeneca launched, at the onset of November 2021, the Phase 3 SAMETA clinical trial. During the trial,…

Continue Reading ICYMI: Trial Begins to Evaluate Savolitinib and IMFINZI for Renal Cell Carcinoma
Study: Tivozanib As a Treatment for Advanced Renal Cell Carcinoma
Photo by Robina Weermeijer on Unsplash

Study: Tivozanib As a Treatment for Advanced Renal Cell Carcinoma

Recently the Kidney Cancer Association held its International Kidney Cancer Symposium, where medical professionals and other industry members come together to share ideas and push for innovative research and treatments…

Continue Reading Study: Tivozanib As a Treatment for Advanced Renal Cell Carcinoma
Wake Forest Baptist Comprehensive Cancer Center Receives $2.5M Grant for Organoid Research
stevepb / Pixabay

Wake Forest Baptist Comprehensive Cancer Center Receives $2.5M Grant for Organoid Research

  Recently, the National Cancer Institute provided a $2.5M grant to support specialized medical research being performed at the Wake Forest Organoid Research Center (WFORCE). According to the press release,…

Continue Reading Wake Forest Baptist Comprehensive Cancer Center Receives $2.5M Grant for Organoid Research